Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma

Authors: Ahmed S Abdulamir, Rand R Hafidh, Layla K Mahdi, Tarik Al-jeboori, Fatimah Abubaker

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

The seroprevalence of IgG antibodies of Streptococcus gallolyticus subspecies gallolyticus, CIP 105428, was evaluated to investigate the controversial association of S. gallolyticus with colorectal carcinoma and adenoma in attempt to investigate the nature of such association if any, by exploring the mRNA expression of NF-κB and IL-8. Moreover, the serological behavior of S. gallolyticus IgG antibodies was compared to that of an indicator bacterium of bowel, Bacteroides fragilis.

Methods

ELISA was used to measure IgG antibodies of S. gallolyticus and B. fragilis in sera of 50 colorectal cancer, 14 colorectal adenoma patients, 30 age- and sex- matched apparently healthy volunteers (HV) and 30 age- and sex- matched colonoscopically-proven tumor-free control subjects. NF-κB and IL-8 mRNA expression was evaluated in tumorous and non-tumorous tissue sections of carcinoma and adenoma patients in comparison with that of control subjects by using in situ hybridization assay.

Results

Colorectal cancer and adenoma patients were associated with higher levels of serum S. gallolyticus IgG antibodies in comparison with HV and control subjects (P < 0.05) while no similar association was found with serum IgG antibodies of B. fragilis (P > 0.05). ELISA cutoff value for the seropositivity of S. gallolyticus IgG was calculated from tumor-free control group. The expression of NF-κB mRNA was higher in tumorous than non-tumorous tissue sections of adenoma and carcinoma, higher in carcinoma/adenoma sections than in control subjects, higher in tumorous sections of carcinoma than in adenoma patients, and higher in S. gallolyticus IgG seropositive than in seronegative groups in both tumorous and non-tumorous sections (P < 0.05). IL-8 mRNA expression in tumorous sections of adenoma and carcinoma was higher than in non-tumorous sections, higher in carcinoma/adenoma than in control subjects, and higher in S. gallolyticus IgG seropositive than in seronegative groups in tumorous rather than non-tumorous sections (P < 0.05).

Conclusion

S. gallolyticus most likely plays an essential role in the oncogenic progression of normal colorectal mucosa to adenoma and to CRC. This promoting/propagating role of S. gallolyticus might take place by utilizing certain inflammatory, anti-apoptotic, and angiogenic factors of transformation including NF-κB and IL-8.
Appendix
Available only for authorised users
Literature
1.
Crawford JM, Kumar V: The oral cavity and the gastrointestinal tract. Basic Pathology. Edited by: Kumar V, Cotran RS, Robbins SL. 2003, Philadelphia and London: Saunders and Elsevier Science, 543-590. Seven
2.
Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB: Bacterial infection promotes colon tumorigenesis in Apc (Min/+) mice. J Infect Dis. 2001, 184: 227-30. 10.1086/321998.CrossRefPubMed
3.
Jordane B, Nguyen IS, Pini A, Gossé F, Richert S, Thiersé D, Van Dorsselaer A, Leize-Wagner E, Raul F, Klein JP, Schöller-Guinard M: Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis. 2004, 25: 1477-84. 10.1093/carcin/bgh091.CrossRef
4.
Leport C, Bure A, Leport J, Vilde JL: Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. The Lancet. 1997, 1: 748-
5.
Zarkin BA, Lillimoe KD, Cameron JL, Efforon PN, Magnuson TH, Pitt HA: The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg. 1990, 211: 786-92. 10.1097/00000658-199006000-00019.CrossRefPubMedPubMedCentral
6.
Fagundes JJ, Noujain HM, Coy CSR, Ayrizono MLS, Góes JRN, Martinuzzo WRG, Costa AM, Medeiros RR, Leonardi LS: Association between bacterial endocarditis and neoplasia in relation to 4 cases. Rev Bras Coloproctol. 2000, 20: 95-9.
7.
Ruoff KL, Miller SI, Garner CV, Ferraro MJ, Calderwood SB: Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol. 1989, 27: 305-308.PubMedPubMedCentral
8.
Devriese LA, Vandamme P, Pot B, Vanrobaeys M, Kersters P, Haesebrouck F: Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants. J Clin Microbiol. 1998, 36: 3520-3523.PubMedPubMedCentral
9.
Schlegel L, Francine G, Elisabeth A, Patrick AD: Reappraisal of the taxonomy of the Streptococcusbovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol. 2003, 53: 631-645. 10.1099/ijs.0.02361-0.CrossRefPubMed
10.
11.
Linko-Kettunen L, Arstila P, Jalkanen M, Jousimies-Somer H, Lassila O, Lehtonen OP, Weintraub A, Viljanen MK: Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide. J Clin Microbiol. 1984, 20: 519-24.PubMedPubMedCentral
12.
13.
Westrin KM, Stierna P, Weintraub A, Palmgren AC, Nord CE: Serum antibody response to Bacteroides fragilis in experimental sinusitis. Infection. 1991, 19: 435-9. 10.1007/BF01726458.CrossRefPubMed
14.
Delahooke DM, Barclay GR, Poxton IR: Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species. Infect Immun. 1995, 63: 840-6.PubMedPubMedCentral
15.
Abdulamir AS, Hafidh RR, Mahdi LK, Aljeboori T, Abubakar F, Abbas KA: The Interplay between p53 and p21 Tumor Suppressor Proteins in the Transformation of Colorectal Adenoma to Carcinoma. Am J Immunol. 2008, 4: 14-22. 10.3844/ajisp.2008.14.22.CrossRef
16.
Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS: Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann Periodontol. 2001, 6: 20-29. 10.1902/annals.2001.6.1.20.CrossRefPubMed
17.
Bartchewsky W, Martini MR, Masiero M, Squassoni AC, Alvarez MC, Ladeira MS, Salvatore D, Trevisan M, Pedrazzoli J, Ribeiro ML: Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol. 2009, 44: 153-161. 10.1080/00365520802530853.CrossRefPubMed
18.
Srinivasan M, Sedmak D, Jewell S: Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002, 161: 1961-71.CrossRefPubMedPubMedCentral
19.
Lisowski AR, English ML, Opsahl AC, Bunch RT, Blomme EA: Effect of the storage period of paraffin sections on the detection of mRNAs by in situ hybridization. J Histochem Cytochem. 2001, 49: 927-8.CrossRefPubMed
20.
Vanbrobaeys M, Haesebrouck F, Ducatelle R, De Herdt P: Identifcation of virulence associated markers in the cell wall of pigeon Streptococcus gallolyticus strains. Vet Microbiol. 2000, 73: 319-325. 10.1016/S0378-1135(00)00159-0.CrossRef
21.
Weintraub A, Larsson BE, Lindberg AA: Chemical and immunochemical analyses of Bacteroides fragilis lipopolysacharides. Infect Immune. 1985, 49: 197-201.
22.
Schuurs A, Weeman V: Enzyme innunoassay. Clin Chem Acta. 1977, 31: 1-40. 10.1016/0009-8981(77)90410-7.CrossRef
23.
Al-Murrani WK, Al-Shummari A, Al-Obaidi A, Mustafa AM: New approach for the calculation of the cutoff value(value) in immunological and diagnostic tests. Iraqi J Microbiol. 2000, 12: 1-9.
24.
Kadhim H, Aljeboori T, Tawfik M: Possible role of cell cycle regulatory proteins and nuclear factor-κB on the pathogenesis of transitional cell carcinoma of the bladder. PhD Thesis. 2004, Al-Nahrain University, Microbiology Department
25.
Konstantinovsky S, Søren N, Mogens V: Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Breast Cancer Res Treat. 2005, 10: 322-28.
26.
Panwalker AP: Unusual infections associated with colonic cancer. Rev Infect Dis. 1991, 10: 347-CrossRef
27.
Darjee R, Gibb AP: Serological investigation into the association between Streptococcus bovis and colonic cancer. J Clin Pathol. 1993, 46: 1116-9. 10.1136/jcp.46.12.1116.CrossRefPubMedPubMedCentral
28.
Wanke CA, Bistrian B: Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucine glycoprotein, and the HT29-C1 intestinal cell line. Nutrition. 1997, 13: 959-964. 10.1016/S0899-9007(97)00337-7.CrossRefPubMed
29.
Grizzle WE, Shibata D, Manne U: Molecular and Histopathologic Changes in the Development of Colorectal Neoplasia. Molecular Pathology of Early Cancer. Edited by: Srivastava S, Henson DE, Gazdar A. 1999, Washington DC: IOS Press, 135-170. 1
30.
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE: Aberrant nuclear factor-_B/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1997, 100: 2952-2960. 10.1172/JCI119848.CrossRefPubMedPubMedCentral
31.
Gilmore TD, Morin PJ: The I-κB protein: members of a multifunctional family. Trends Gene. 1993, 9: 427-433. 10.1016/0168-9525(93)90106-R.CrossRef
32.
Devalaraja MN, Wang DZ, Ballard DW, Richmond A: Elevated constitutive I-κB kinase activity and IκB phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-_transcription. Cancer Res. 1999, 59: 1372-1377.PubMed
33.
Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V: Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells. Oncogene. 1999, 18: 2567-2577. 10.1038/sj.onc.1202599.CrossRefPubMed
34.
Wang Wei, He-Sheng L, Bao-Ping Yu: Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol. 2004, 10: 177-181.PubMedPubMedCentral
35.
Janeway CA, Travers P: Immunobiology: the Immune System in Health and Disease. 1997, Garland Publishing Inc: New Yorkand London
36.
Ohshima H, Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. 1994, 305: 253-264.CrossRefPubMed
37.
Chen F, Castranova V, Shi X, Demers LM: New insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of Diseases. Clin Chem. 1999, 45: 7-17.PubMed
38.
Ellmerich S, Schöller M, Duranton B, Gossé F, Galluser M, Klein JP, Raul F: Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 2000, 21: 753-756. 10.1093/carcin/21.4.753.CrossRefPubMed
39.
Mukaida N: Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000, 72: 391-398.PubMed
Metadata
Title
Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma
Authors
Ahmed S Abdulamir
Rand R Hafidh
Layla K Mahdi
Tarik Al-jeboori
Fatimah Abubaker
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-403

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue

Research article

Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells

Research article

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters

Research article

Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells

Research article

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo

Study protocol

Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme

Research article

Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits